<DOC>
	<DOCNO>NCT00068133</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability VLTS-589 compare placebo , administer bilaterally low extremity , subject intermittent claudication determine effect VLTS-589 peak walking time ( PWT ) subject receive VLTS-589 compare subject receive placebo .</brief_summary>
	<brief_title>Trial VLTS-589 Subjects With Intermittent Claudication</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Inclusion criterion : Men woman 40 80 year age , Must give informed consent , Current medical history peripheral arterial disease , include follow symptom : leg pain , leg discomfort leg weakness Exclusion criterion : Ulcers gangrene , History cancer ( except skin cancer ) within past 5 year , Participation another clinical trial within 30 day enrollment trial , Unwillingness inability comply study requirement</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2005</verification_date>
</DOC>